OCT images were acquired using frequency domain (FD-OCT; C7-XR OCT Intravascular Imaging System; St. Jude Medical Inc., St. Paul, Minnesota) or time domain (TD-OCT; M2/M3 Cardiology Imaging System; LightLab Imaging Inc., Westford, Massachusetts) OCT. Although there are some differences, both systems use light sources with the same center wavelength (1300nm) and bandwidth, resulting in similar axial resolution (15μm). Therefore, it is unlikely that the evaluation of plaque components including fibrous cap thickness would have been affected by the differences between the two systems.
All OCT plaque morphologies were analyzed using previously validated criteria [1] [2] [3] .
Fibrous cap thickness (FCT) was measured at its thinnest part 3 times and the average value was calculated. Thin-cap fibroatheroma (TCFA) was defined as a lipid plaque with the thickness of fibrous cap below 65 µm. Lipid arc and lipid length were measured on the crosssectional image and longitudinal reconstructed view, respectively. Lipid volume index was defined as the product of averaged lipid arc multiplied by lipid length 4, 5 . Cholesterol crystals were defined as thin linear regions of high light intensity without signal attenuation 6 .
Microchannels were defined as small black holes of diameter 50-100 µm that were present on at least 3 consecutive cross-sectional frames 7 . Thrombus was defined as a mass > 250 µm 8 attached to the luminal surface or floating within the lumen. Calcifications were identified as low backscatter areas with sharp borders. Macrophage infiltration was defined as signalrich, distinct, or confluent punctuated regions that exceeded the intensity of background speckle noise 9 and assessed semi-quantitatively using a previously described grading system 10 . In brief, macrophages were graded every 1mm interval along the entire plaque as follows: 
3D thin-cap area measurement
To volumetrically assess the three-dimensional fibrous cap, we applied a previously validated computer algorithm ( Figure S1 ). The fibrous cap and luminal boundary were semiautomatically segmented by the algorithm in all frames along the entire plaque. Two independent analysts who were blinded to the clinical information including timepoint adjusted the boundaries if there was a segmentation error. With the fully segmented fibrous cap, the algorithm quantified the thickness at each point of its luminal boundary. The fibrous cap area was calculated as the product of the frame interval and the arc length of fibrous cap summed over involved frames. 
Statistical methods
To explore the independent clinical predictors of the change in the thin-cap area, we included the 'statin naïve' and 'low-intensity statin' covariates in the model in addition to the conventional clinical factors because previous studies reported that both statin intake 11 and dose 12 effected the chronological change of FCT. We also included the baseline thin-cap area inthe model because we observed a trend of greater change in plaques with larger baseline thin-cap area ( Figure 1 ). Unadjusted values are described in Table S1 . Intra-and inter-observer agreement of calculating the macrophage grade was evaluated by intraclass correlation coefficient (ICC) based on the random effects analysis of variance model. 
